（原标题：科百特商业秘密侵权案落槌，国产创新如何打赢知识产权保卫战？） 过滤膜，作为广泛应用于生命科学、半导体微电子等领域的关键材料之一，通过微米级、纳米级等的精 度孔过滤杂质，保证干净效率。国内生物制药用除病毒滤膜产品，长期被思拓凡（Cytiva）、默克密理 博（Merck-Millipore）等海外企业垄断。 近期，一项制约我国高新技术产业的关键材料技术的诉讼阶段性进展引发大众关注。过滤膜国产代表企 业科百特与同业公司赛普就侵犯商业秘密一案终审宣判，根据科百特发布的公告，赛普(杭州)过滤科技 有限公司(系东富龙生命科技有限公司子公司)侵犯公司商业秘密案，杭州市萧山区人民法院已正式作出 判决。法院判决赛普公司构成单位犯罪，赛普公司法定代表人郑某某及科百特前员工朱某某、王某均依 法承担刑事责任，判决已生效。有关人员判处一年十一个月至二年九个月有期徒刑，企业及相关人员需 支付罚金及赔偿金共计1450万元。 对此，有券商医药行业分析师对21世纪经济报道记者指出，此次科百特诉赛普公司（东富龙子公司）商 业秘密侵权案获刑事判决，标志着我国高端过滤膜领域"技术保卫战"取得阶段性突破。 长期以来，生物制药除病毒滤膜等核心 ...

过滤膜，作为广泛应用于生命科学、半导体微电子等领域的关键材料之一，通过微米级、纳米级等的精 度孔过滤杂质，保证干净效率。国内生物制药用除病毒滤膜产品，长期被思拓凡（Cytiva）、默克密理 博（Merck-Millipore）等海外企业垄断。 近期，一项制约我国高新技术产业的关键材料技术的诉讼阶段性进展引发大众关注。过滤膜国产代表企 业科百特与同业公司赛普就侵犯商业秘密一案终审宣判，根据科百特发布的公告，赛普(杭州)过滤科技 有限公司(系东富龙生命科技有限公司子公司)侵犯公司商业秘密案，杭州市萧山区人民法院已正式作出 判决。法院判决赛普公司构成单位犯罪，赛普公司法定代表人郑某某及科百特前员工朱某某、王某均依 法承担刑事责任，判决已生效。有关人员判处一年十一个月至二年九个月有期徒刑，企业及相关人员需 支付罚金及赔偿金共计1450万元。 长期以来，生物制药除病毒滤膜等核心过滤材料被海外巨头如Cytiva、默克密理博等垄断，国内企业不 仅面临技术追赶压力，更因知识产权保护不足导致"研发成果易被窃取"的高风险环境。 "本案中，科百特前员工携技术秘密跳槽至竞争对手并实施侵权，本质上是本土产业链'内耗式竞争'的 缩影。若 ...

Core Viewpoint - The company has approved a guarantee amount of RMB 500 million for its subsidiaries, with a current external guarantee balance of RMB 360.4 million, representing 69.98% of the company's latest audited net assets [1][22]. Summary by Sections Guarantee Review Overview - The company held board meetings on April 25 and May 16, 2025, to approve the guarantee amount for its subsidiaries, which is set at RMB 500 million, effective until the next annual general meeting [1]. Guarantee Amount Adjustment - The company adjusted the unused guarantee amounts of its wholly-owned subsidiaries, transferring RMB 20 million from Cangzhou Mingzhu Lithium Battery Diaphragm Co., Ltd. and RMB 10 million from Wuhu Mingzhu Plastic Co., Ltd. to Cangzhou Mingzhu Diaphragm Technology Co., Ltd., resulting in new available amounts of RMB 47.5 million, RMB 0 million, and RMB 34 million respectively [2]. Guarantee Progress - On September 26, 2025, the company signed a maximum guarantee contract with China Bank for a loan of RMB 10 million for its subsidiary, Dezhou Donghong Membrane Technology Co., Ltd. [3] - On September 28, 2025, the company signed two maximum guarantee contracts with Shanghai Pudong Development Bank for Cangzhou Diaphragm Technology Co., Ltd. and Cangzhou Lithium Battery Diaphragm Co., Ltd., each for RMB 10 million [3]. Basic Information of Guaranteed Entities - Cangzhou Mingzhu Diaphragm Technology Co., Ltd. was established on January 21, 2014, with a registered capital of RMB 62.66 million and is wholly owned by the company [5]. - Cangzhou Mingzhu Lithium Battery Diaphragm Co., Ltd. was established on February 17, 2016, with a registered capital of RMB 50 million and is also a wholly-owned subsidiary [7]. - Dezhou Donghong Membrane Technology Co., Ltd. was established on June 29, 2009, with a registered capital of RMB 8 million and is a wholly-owned subsidiary of Cangzhou Mingzhu Diaphragm Technology Co., Ltd. [9]. Main Content of Guarantee Agreements - The guarantee agreements for Cangzhou Diaphragm Technology and Cangzhou Lithium Battery Diaphragm include a maximum guarantee amount of RMB 10 million each, with a guarantee period extending three years after the debt fulfillment period [10][14]. - The guarantee agreement for Dezhou Donghong Membrane Technology includes a maximum guarantee amount of RMB 1 million, with a similar three-year guarantee period [18][19]. Board of Directors' Opinion - The board believes that the subsidiaries have stable operations and good asset quality, and the guarantee will support their business development and improve operational efficiency, benefiting the company's overall interests [21]. Company’s Cumulative External Guarantee Situation - As of the announcement date, the company has provided guarantees totaling RMB 500 million, which is 66.08% of the total audited assets and 97.08% of the audited net assets as of the end of 2024 [22]. - The current external guarantee balance is RMB 360.4 million, representing 47.63% of total audited assets and 69.98% of audited net assets as of the end of 2024 [22]. Additional Information - The company has no overdue guarantees or litigation related to guarantees as of the announcement date [23].

Group 1 - The collaboration between Hangzhou Lingbo Precision Machinery Co., Ltd. and Kobot is a significant achievement, marking the entry of Lingbo into Kobot's supplier list after a rigorous selection process [2][3] - Kobot, a global leader in the filtration membrane industry, is experiencing a surge in orders due to the domestic semiconductor industry's push for localization, leading to an urgent need for high-quality local suppliers [3][4] - The local government, specifically the Xiaoshan Economic and Information Bureau, played a crucial role in facilitating this partnership by identifying and matching potential suppliers with Kobot's stringent requirements [3][4] Group 2 - Kobot aims to replace over 1,000 imported components in integrated circuit processes and plans to open 40% of its 3,000 R&D tasks to domestic collaboration, which presents significant opportunities for local manufacturers [4] - The integration of local companies like Lingbo into Kobot's supply chain is expected to drive the transformation and upgrading of Xiaoshan's manufacturing sector, enhancing the overall competitiveness of local enterprises [4] - The Xiaoshan Economic and Information Bureau is shifting its focus from merely linking product supply chains to fostering deeper technological collaboration among local manufacturers, research institutions, and universities [5]